Moberg Pharma AB (publ) (STO:MOB)
Sweden
· Delayed Price · Currency is SEK 9.01
-0.09 (-1.04%)
At close: Dec 5, 2025
Moberg Pharma AB Revenue
Moberg Pharma AB had revenue of 4.01M SEK in the quarter ending September 30, 2025, with 3.89% growth. This brings the company's revenue in the last twelve months to 12.50M, up 42.27% year-over-year. In the year 2024, Moberg Pharma AB had annual revenue of 9.81M.
Revenue (ttm)
12.50M
Revenue Growth
+42.27%
P/S Ratio
33.87
Revenue / Employee
2.08M
Employees
10
Market Cap
423.24M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 27.85B |
| Getinge AB | 35.85B |
| Sectra AB | 3.37B |
| Camurus AB | 2.35B |
| Medicover AB | 25.67B |
| Asker Healthcare Group AB | 16.41B |
| BioArctic AB | 1.92B |
| AddLife AB | 10.53B |